SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-24-037759
Filing Date
2024-09-23
Accepted
2024-09-23 07:30:23
Documents
3
Period of Report
2024-09-23

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 30135
2 ex99-1.htm EX-99.1 46472
3 ex99-1_001.jpg GRAPHIC 6587
  Complete submission text file 0001493152-24-037759.txt   87152
Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7
Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7 843-900-3201
COSCIENS Biopharma Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 241314639
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)